Anthrax post-vaccinal cell-mediated immunity in humans: Kinetics pattern

Vaccine

Volumn 15, Issue 6-7, 1997, Pages 631-636

  Shlyakhov, Elie ^a   Rubinstein, Ethan ^a   Novikov, Ilya ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

anthrax; Anthraxin test; human vaccination

Indexed keywords

ANTHRAX TOXIN; LIVE VACCINE;

ADOLESCENT; ADULT; AEROSOL; ANTHRAX; ARTICLE; BACILLUS ANTHRACIS; CELLULAR IMMUNITY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ERYTHEMA; FEMALE; GUINEA PIG; HUMAN; INHALATIONAL DRUG ADMINISTRATION; INTRACARDIAC DRUG ADMINISTRATION; INTRADERMAL DRUG ADMINISTRATION; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SKIN MANIFESTATION; SKIN TEST; SUBCUTANEOUS DRUG ADMINISTRATION; VACCINATION;

ADOLESCENT; ADULT; ANTIGENS, BACTERIAL; BACILLUS ANTHRACIS; BACTERIAL TOXINS; BACTERIAL VACCINES; FEMALE; HUMANS; IMMUNITY, CELLULAR; KINETICS; MALE; MIDDLE AGED; SKIN TESTS;

EID: 0030898162     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(96)00286-1     Document Type: Article

References (38)

1. Metchnikoff, E. L'immunite dans les maladies infectieuses. Masson, Paris, 1901
2. Bail, O. Beziehungen zwischen Aggressivitat und Leibesubstanz von Bakterien. Munch. med. Wschr. 1905, 40, 1935-1937
3. Bail, O. and Weil, E. Beitrage zum Studium der Milzbrandinfektion. Arch. Hyg. 1911, 73, 218-264
4. Stamatin, N. and Stamatin, L. Le pouvoir immunisant de souches acapsulogenes du B. anthracis. C.R. Soc. Biol. 1936, 122, 491-193
5. Sterne, M. The use of anthrax vaccines prepared from avirulent (unencapsulated) variants of Bacillus anthracis. Onderstepoort J. Vet. Sci. An. Ind. 1939, 13, 307-312
6. Shlyakhov, E.N. and Rubinstein, E. Human anthrax live vaccine. Vaccine 1994, 12, 727-730
7. Mikesell, O.H.P., Ivins, B.E., Ristroph, J.D. and Drier, T.M. Evidence of plasmid-mediated toxin production in Bacillus anthracis. Infect. Immunol. 1983, 39, 371-376
8. Turnbull, P.C.B. Anthrax vaccines: past, present and future. Vaccine 1991, 9, 533-539
9. Ivins, B.E. and Welkos, S.L. Recent advances in the development of an improved human anthrax vaccine. Eur. J. Epidemiol. 1988, 4, 12-19
10. Hanna, P.C., Kochi, S. and Collier, R.J. Biochemical and physiological changes induced by anthrax lethal toxin in J774 macrophage-like cells. Mol. Biol. Cell. 1992, 3, 1269-1277
11. Hanna, P.C., Acosta, D. and Collier, R.J. On the role of macrophages in anthrax. Proc. Natl Acad. Sci. USA 1993, 90, 10198-10201
12. Hambleton, P. and Turnbull, P.C.B. Anthrax vaccine development: a continuing story. In: Bacterial Vaccines, Alan R. Liss, New York, 1990, Vol. 13, pp. 105-122
13. Turnbull, P.C.B., Leppla, S.H., Broster, M.G., Quinn, C.P. and Melling, J. Antibodies to anthrax toxin in humans and guinea pigs and their relevance to protective immunity. Med. Microbiol. Immunol. 1988, 177, 293-303
14. Little, S.F. and Knudson, G.B. Comparative efficacy of Bacillus anthracis live spore vaccine and protective antigen vaccine against anthrax in guinea pigs. Infect. Immunol. 1986, 52, 509-512
15. Ivins, B.E., Fellows, P.F. and Nelson, G.O. Efficacy of a standard human anthrax vaccine against Bacillus anthracis spore challenge in guinea pigs. Vaccine 1994, 12, 872-874
16. Walker, P.D. Bacterial vaccines: old and new, veterinary and medical. Vaccine 1992, 10, 977-990
17. Coulson, N.M., Fulop, M. and Titbal, R.W. Bacillus anthracis protective antigen, expressed in Salmonella typhimurium SL 3261, affords protection against anthrax spore challenge. Vaccine 1994, 12, 1395-1401
18. Ezzell, J.W.Jr and Abshire, T.G. Immunological analysis of cell-associated antigens of Bacillus anthracis. Infect. Immunol. 1988, 56, 349-356
19. Farrar, W.E. Anthrax: virulence and vaccines. Ann. Intern. Med. 1994, 121, 379-380
20. Shlyakhov, E.N. Development and experimental study of a product revealing an allergic reaction in anthrax. In: Interinstitute Scientific Conference on Strains, Standards, and Diagnostic Products, Abstracts. Leningrad, 1957, pp. 53-55
21. Shlyakhov, E.N. Allergy in Anthrax. Kartia Moldoveniaska, Kishinev, 1968, p. 188
22. Shlyakhov, E.N. and Shroit, I.G. Pathomorphological changes into skin in the anthraxin allergic test. J. Epidemiol. 1964, 8, 307-312
23. Shlyakhov, E.N. and Rubinstein, E. Ou en est le diagnostic du charbon?. Bull. Soc. Path. Ex. 1992, 85, 215-218
24. Shlyakhov, E.N. and Rubinstein, E. Diagnostic retrospectif du charbon bacteridien. Med. Trop. 1993, 53, 55-59
25. Shlyakhov, E.N. and Rubinstein, E. Hypersensibilite retardee charbonneuse postvacinale, 1. Etude chez les cobayes vaccines contre le charbon. Med. Trop. 1994, 54, 33-37
26. Gruz, E.V. Interaction between anthraxin and hyperimmune anthrax serum and of its globulin fraction. In: Topics of Immunoprevention and Immunodiagnostic. Timpul, Kishinev, 1970, pp. 250-252
27. Afifi, A.A. and Azen, S.P. Statistical Analysis: A Computer-oriented Approach. Academic Press, New York, 1972
28. Armitage, P. Statistical Methods in Medical Research. Blackwell Scientific, Oxford, 1971
29. Shroit, I.G., Shlyakhov, E.N., Sorokina, L.M., Gruz, E.V. and Burdenko, T.A. Immunomorphological reaction to vaccine STI and to anthrax toxin. In: Problems of Particularly Dangerous Infections. All-Union Anti-plague Institute "Microbe", Saratov, 1974, Vol. 4, pp. 89-96
30. Shlyakhov, E.N., Shroit, I.G. and Burdenko, T.A. Immunomorphologic and allergologic features of experimental vaccination against anthrax. In: Topics of Experimental and Applied Immunology. Kartia Moldoveniaska, Kishinev, 1967, pp. 69-75
31. Shlyakhov, E.N. and Rubinstein, E. Isolation of the vaccinal strain and induction of cell-mediated immunity in guinea pigs vaccinated against anthrax. In: 14e Reun. Interdiscipl. Chimiotherap. anti-infectieuse. The Congress Committee, Paris, 1994. Abstract No. 402
32. Welkos, S.L., Trotter, R.W., Becker, D.M., Nelson, G.O. and Resistance to the Sterne strain of B. anthracis phagocytic cell responses of resistant and susceptible mice. Microbiol. Pathogen. 1989, 7, 15-35
33. Welkos, S.L. and Friedlander, A.M. Pathogenesis and genetic control of resistance to the Sterne strain of Bacillus anthracis. Microbiol. Pathol. 1988, 4, 53-69
34. Friedlander, A.M., Bathnagar, R., Leppla, S.H., Johnson, L. and Singh, Y. Characterization of macrophage sensitivity and resistance to anthrax lethal toxin. Infect. Immunol. 1993, 61, 245-252
35. Friedlander, A.M. Macrophages are sensitive to anthrax lethal toxin through an acid-dependent process. J. Biol. Chem. 1986, 261, 7123-7126
36. Grinberg, L.M. and Abramova, A.A. Pathological anatomy of anthrax sepsis according to data of the Sverdlovsk outbreak in 1979. Arkh. Pathologii. 1993, 55, 23-26
37. Sergeeva, L.V. Anthrax morbidity in humans vaccinated against anthrax. In: Current Problems of Infectious Diseases Epidemiology. Ministry of Health, Moscow, 1980, pp. 173-176
38. Shlyakhov, E., Gruz, E. and Prisacari, V. Anthrax. Shtiintza, Kishinev, 1975